Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The purpose of the study was to evaluate endocrine patterns of patients with congenital adrenal hyperplasia and each gene mutation and to analyze the correlation between each phenotype and genotype. Methods: This was a retrospective study of the patients with congenital adrenal hyperplasia in the pediatric outpatient clinic at the Samsung Medical Center from November 1994 to December 2012. We analyzed the medical records of 27 patients (male, 19; female, 8) with congenital adrenal hyperplasia who had been diagnosed by genetic testing to have 21-hydroxylase deficiency. Results: In genetic analysis of 54 alleles from 27 patients, 13 types of mutations were identified. The distribution of 21-hydroxylase deficiency gene mutations revealed that intron 2 splice site (c.293-13A/C＞G ) mutations and large deletions were the most common, at 31.5% and 22.2% respectively, followed by p.I173N, p.R356W, and p.I172N mutations at 11.1%, 9.3%, and 9.3%, respectively. Other mutations were observed at 1.9–3.7%. No novel mutations were detected Conclusion: The analysis of 54 alleles revealed 13 types of mutation. The salt wasting form showed a good correlation between genotype and phenotype, but the simple virilizing and nonclassic forms showed inconsistencies between genotype and phenotype. The distribution of CYP21A2 mutations was evaluated for 21-hydroxylase deficiency patients from a single center. This study provides limited data on mutation spectrum and genotype-phenotype correlation of 21-hydroxylase deficiency in Korea.
Abstract
Purpose: The purpose of the study was to evaluate endocrine patterns of patients with congenital adrenal hyperplasia and each gene mutation and to analyze the correlation between each phenotype and genotype. Methods: This was a retrospective study of the patients with congenital adrenal hyperplasia in the pediatric outpatient clinic at the Samsung Medical Center from November 1994 to December 2012. We analyzed the medical records of 27 patients (male, 19; female, 8) with congenital adrenal hyperplasia who had been diagnosed by genetic testing to have 21-hydroxylase deficiency. Results: In genetic analysis of 54 alleles from 27 patients, 13 types of mutations were identified. The distribution of 21-hydroxylase deficiency gene mutations revealed that intron 2 splice site (c.293-13A/C＞G ) mutations and large deletions were the most common, at 31.5% and 22.2% respectively, followed by p.I173N, p.R356W, and p.I172N mutations at 11.1%, 9.3%, and 9.3%, respectively. Other mutations were observed at 1.9–3.7%. No novel mutations were detected Conclusion: The analysis of 54 alleles revealed 13 types of mutation. The salt wasting form showed a good correlation between genotype and phenotype, but the simple virilizing and nonclassic forms showed inconsistencies between genotype and phenotype. The distribution of CYP21A2 mutations was evaluated for 21-hydroxylase deficiency patients from a single center. This study provides limited data on mutation spectrum and genotype-phenotype correlation of 21-hydroxylase deficiency in Korea.
참고문헌 (39)
- Krone N, "Genetics of congenital adrenal hyperplasia", Best Pract Res Clin Endocrinol Metab, 23, pp.181~192 (2009)
- White PC, "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Endocr Rev, 21, pp.245~291 (2000)
- Trakakis E, "An update to 21-hydroxylase deficient congenital adrenal hyperplasia", Gynecol Endocrinol, 26, pp.63~71 (2010)
- Pang S, "Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Trends Endocrinol Metab, 1, pp.300~307 (1990)
- Speiser PW, "High frequency of nonclassical steroid 21-hydroxylase deficiency", Am J Hum Genet, 37, pp.650~667 (1985)
- Raiti S, "Congenital adrenal hyperplasia", Arch Dis Child, 39, pp.324~333 (1964)
- Speiser PW, "Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency", J Clin Invest, 90, pp.584~595 (1992)
- New MI, "An update of congenital adrenal hyperplasia", Ann N Y Acad Sci, 1038, pp.14~43 (2004)
- Kaplan SA, "Diseases of the adrenal cortex: II. Congenital adrenal hyperplasia", Pediatr Clin North Am, 26, pp.77~89 (1979)
- Speiser PW, "Nonclassic adrenal hyperplasia", Rev Endocr Metab Disord, 10, pp.77~82 (2009)
- White PC, "Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man", Proc Natl Acad Sci U S A, 82, pp.1089~1093 (1985)
- Wedell A, "Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation", J Clin Endocrinol Metab, 78, pp.1145~1152 (1994)
- Lee HH., "CYP21 mutations and congenital adrenal hyperplasia", Clin Genet, 59, pp.293~301 (2001)
- "CYP21A2: CYP 21A1 allele nomenclature" (2013)[URL]
- Greulich WW, "Radiographic atlas of skeletal development of hand and wrist" (1959), Stanford University Press
- Speiser PW, "Congenital adrenal hyperplasia", N Engl J Med, 349, pp.776~788 (2003)
- Higashi Y, "Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene", Proc Natl Acad Sci U S A, 83, pp.2841~2845 (1986)
- Tusie-Luna MT, "Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms", Proc Natl Acad Sci U S A, 92, pp.10796~10800 (1995)
- Parajes S, "High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency", PLoS One, 3, pp.e2138~ (2008)
- Higashi Y, "Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency", J Biochem, 109, pp.638~644 (1991)
- Amor M, "Mutation in the CYP21B gene (Ile-172: Asn) causes steroid 21-hydroxylase deficiency", Proc Natl Acad Sci U S A, 85, pp.1600~1604 (1988)
- Speiser PW, "Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency", J Clin Endocrinol Metab, 64, pp.86~91 (1987)
- Tusie-Luna MT, "A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele", Mol Endocrinol, 5, pp.685~692 (1991)
- Nikoshkov A, "Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency", J Clin Endocrinol Metab, 82, pp.194~199 (1997)
- New MI, "Growth and final height in classical and nonclassical 21-hydroxylase deficiency", Acta Paediatr Jpn, 30, pp.79~88 (1988)
- Soliman AT, "Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog", Metabolism, 46, pp.513~517 (1997)
- Cornean RE, "Obesity in 21-hydroxylase deficient patients", Arch Dis Child, 78, pp.261~263 (1998)
- Manoli I, "Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome", Clin Endocrinol (Oxf), 57, pp.669~676 (2002)
- Wilkins L, "The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia", Bull Johns Hopkins Hosp, 86, pp.249~252 (1950)
- Bartter FC, "Congenital adrenal hyperplasia associated with the adrenogenital syndrome: an attempt to correct its disordered hormonal pattern", J Clin Invest, 29, pp.797~ (1950)
- Choi JH, "Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency", Exp Clin Endocrinol Diabetes, 120, pp.23~27 (2012)
- Finkielstain GP, "Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency", J Clin Endocrinol Metab, 96, pp.E161~E172 (2011)
- Friaes A, "CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions", Mol Genet Metab, 88, pp.58~65 (2006)
- Ko JM, "Genotype of steroid 21-hydroxylase gene and clinical characteristics in patients with congenital adrenal hyperplasia 21-hydroxylase deficiency", J Korean Soc Pediatr Endocrinol, 10, pp.57~63 (2005)
- Jin DK, "A study on the relationship between genotype and phenotype in korean patients with congenital adrenogenital syndrome caused by 21-hydroxylase deficiency", J Korean Soc Endocrinol, 15, pp.237~247 (2000)
- Asanuma A, "Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency", J Hum Genet, 44, pp.312~317 (1999)
- Lee HH, "Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency", Mol Genet Metab, 93, pp.450~457 (2008)
- Lee HH, "Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia", J Med Genet, 33, pp.371~375 (1996)
- Schulze E, "Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase", Endocr Res, 21, pp.359~364 (1995)